CFB and infection: Despite the higher serum neutralizing titers to BA.1 in breakthrough infection donors relative to uninfected/mRNA vaccinated individuals, the two cohorts showed similar frequencies of WT- and BA.1-RBD-reactive IgG+ B cells (Fig. 2A and Fig. S3A).